Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Which substitution pharmacotherapy is most effective in treating opioid dependence?Gowing, L.; Ali, R.; White, J.
2009Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationDegenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2004Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centreJittiwutikarn, J.; Ali, R.; White, J.; Bochner, F.; Somogyi, A.; Foster, D.
2000Opioid antagonists and adrenergic agonists for the management of opioid withdrawalGowing, L.; Ali, R.; White, J.
2010Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawalGowing, L.; Ali, R.; White, J.
2002Buprenorphine for the management of opioid withdrawalGowing, L.; Ali, R.; White, J.
2006Opioid antagonists with minimal sedation for opioid withdrawal (review)Gowing, L.; Ali, R.; White, J.; Gowing, L.
2020Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, AustraliaLarney, S.; Jones, N.; Fiellin, D.A.; Nielsen, S.; Hickman, M.; Dobbins, T.; Murphy, T.; Ali, R.; Degenhardt, L.
2009Buprenorphine for the management of opioid withdrawalGowing, L.; Ali, R.; White, J.; Gowing, L.